Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Inherit - A Trial of Pro-Active Genetic Testing in Cancer Patients at St. Vincent's Mayo Clinic Embedded Cancer Center

NCT04456140 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT04456140
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04456140 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Inherit - A Trial of Pro-Active Genetic Testing in Cancer Patients at St. Vincent's Mayo Clinic Embedded Cancer Center
Lead sponsor
Mayo Clinic
Phase
Phase 1
Overall status
Completed
Start date
June 29, 2020
Completion date
September 21, 2021
Enrollment
230 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

breast carcinoma, digestive system neoplasm, malignant brain neoplasm, malignant central nervous system neoplasm, malignant female reproductive system neoplasm, malignant genitourinary system neoplasm, malignant head and neck neoplasm, malignant musculoskeletal neoplasm, malignant solid neoplasm, metastatic malignant neoplasm of unknown primary, skin carcinoma